Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout
Clinical trial NCT03635957 · COMPLETED
Trial details
- NCT number
- NCT03635957
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-26
- Primary completion
- 2019-10-23
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.